BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
69 hedge funds and large institutions have $335M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2017 Q2 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
69
Holders Change
+69
Holders Change %
–
% of All Funds
1.72%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
%
% of All Funds
0.1%
New
69
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$61.2M |
| 2 |
VMI
2
VHCP Management II
New York
|
$37.9M |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$25.9M |
| 4 |
4
BlackRock
New York
|
$25.5M |
| 5 |
KCM
5
Knoll Capital Management
Miami,
Florida
|
$20.2M |
Top Sellers
No sellers this quarter
